Increased Dietary Leucine Reduces Doxorubicin-Associated Cardiac Dysfunction in Rats

Detalhes bibliográficos
Autor(a) principal: Fidale, Thiago Montes
Data de Publicação: 2018
Outros Autores: Antunes, Hanna Karen Moreira [UNIFESP], Santos, Luciano Alex dos, Souza, Fernanda Rodrigues de, Deconte, Simone Ramos, Moura, Francyelle Borges Rosa de, Mantovani, Matheus Matioli, Alves, Poliana Rodrigues, Roever, Leonardo, Resende, Elmiro Santos
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: https://repositorio.unifesp.br/handle/11600/54261
https://dx.doi.org/10.3389/fphys.2017.01042
Resumo: Cardiotoxicity is one of the most significant adverse effects of the oncologic treatment with doxorubicin, which is responsible for a substantial morbid and mortality. The occurrence of heart failure with ventricular dysfunction may lead to severe cardiomyopathy and ultimately to death. Studies have focused on the effects of leucine supplementation as a strategy to minimize or revert the clinical condition of induced proteolysis by several clinical onsets. However, the impact of leucine supplementation in heart failure induced by doxorubicin is unknown. Therefore, the objective of this work is to evaluate the effects of leucine supplementation on the cardiotoxicity in the heart of rats treated with doxorubicin. Rats treated with a 7.5 mg/kg cumulative dose of doxorubicin for 14 days presented a dilatation of the left ventricle (LV), and a reduction of the ejection fraction (FE). The 5% supplementation of leucine in the rats' food prevented the malfunctioning of the LV when administered with doxorubicin. Some alterations in the extracellular matrix remodeling were confirmed by the increase of collagen fibers in the doxorubicin group, which did not increase when the treatment was associated with leucine supplementation. Leucine attenuates heart failure in this experimental model with doxorubicin. Such protection is followed by the maintenance of interstitial collagen fibers.
id UFSP_742c862ed474e791f70c565424308510
oai_identifier_str oai:repositorio.unifesp.br:11600/54261
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Fidale, Thiago MontesAntunes, Hanna Karen Moreira [UNIFESP]Santos, Luciano Alex dosSouza, Fernanda Rodrigues deDeconte, Simone RamosMoura, Francyelle Borges Rosa deMantovani, Matheus MatioliAlves, Poliana RodriguesRoever, LeonardoResende, Elmiro SantosUniversidade Federal de São Paulo (UNIFESP)2020-07-08T13:09:52Z2020-07-08T13:09:52Z2018Frontiers In Physiology. Lausanne, v. 8, p. -, 2018.1664-042Xhttps://repositorio.unifesp.br/handle/11600/54261https://dx.doi.org/10.3389/fphys.2017.01042WOS000422692600001.pdf10.3389/fphys.2017.01042WOS:000422692600001Cardiotoxicity is one of the most significant adverse effects of the oncologic treatment with doxorubicin, which is responsible for a substantial morbid and mortality. The occurrence of heart failure with ventricular dysfunction may lead to severe cardiomyopathy and ultimately to death. Studies have focused on the effects of leucine supplementation as a strategy to minimize or revert the clinical condition of induced proteolysis by several clinical onsets. However, the impact of leucine supplementation in heart failure induced by doxorubicin is unknown. Therefore, the objective of this work is to evaluate the effects of leucine supplementation on the cardiotoxicity in the heart of rats treated with doxorubicin. Rats treated with a 7.5 mg/kg cumulative dose of doxorubicin for 14 days presented a dilatation of the left ventricle (LV), and a reduction of the ejection fraction (FE). The 5% supplementation of leucine in the rats' food prevented the malfunctioning of the LV when administered with doxorubicin. Some alterations in the extracellular matrix remodeling were confirmed by the increase of collagen fibers in the doxorubicin group, which did not increase when the treatment was associated with leucine supplementation. Leucine attenuates heart failure in this experimental model with doxorubicin. Such protection is followed by the maintenance of interstitial collagen fibers.Univ Fed Uberlandia, Lab Expt Med, Uberlandia, MG, BrazilUniv Fed Sao Paulo, Dept Biosci, Sao Paulo, BrazilUniv Fed Uberlandia, Inst Biomed Sci, Uberlandia, MG, BrazilUniv Fed Uberlandia, Veterinarian Hosp, Uberlandia, MG, BrazilUniv Fed Sao Paulo, Dept Biosci, Sao Paulo, BrazilWeb of Science-engFrontiers Media SaFrontiers In PhysiologyDoxorubicinCardiotoxicityLeucineBCAAHeart failureIncreased Dietary Leucine Reduces Doxorubicin-Associated Cardiac Dysfunction in Ratsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleLausanne8info:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESPORIGINALWOS000422692600001.pdfapplication/pdf1704195${dspace.ui.url}/bitstream/11600/54261/1/WOS000422692600001.pdf849526b823b58bb0b9632c3eaca9dc5aMD51open accessTEXTWOS000422692600001.pdf.txtWOS000422692600001.pdf.txtExtracted texttext/plain29681${dspace.ui.url}/bitstream/11600/54261/5/WOS000422692600001.pdf.txt8244cb749f3c37506549e1ebddb287d0MD55open accessTHUMBNAILWOS000422692600001.pdf.jpgWOS000422692600001.pdf.jpgIM Thumbnailimage/jpeg7094${dspace.ui.url}/bitstream/11600/54261/7/WOS000422692600001.pdf.jpge60fa0dfc9d4d79cc430a4676af17b05MD57open access11600/542612023-06-05 19:17:30.629open accessoai:repositorio.unifesp.br:11600/54261Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652023-06-05T22:17:30Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv Increased Dietary Leucine Reduces Doxorubicin-Associated Cardiac Dysfunction in Rats
title Increased Dietary Leucine Reduces Doxorubicin-Associated Cardiac Dysfunction in Rats
spellingShingle Increased Dietary Leucine Reduces Doxorubicin-Associated Cardiac Dysfunction in Rats
Fidale, Thiago Montes
Doxorubicin
Cardiotoxicity
Leucine
BCAA
Heart failure
title_short Increased Dietary Leucine Reduces Doxorubicin-Associated Cardiac Dysfunction in Rats
title_full Increased Dietary Leucine Reduces Doxorubicin-Associated Cardiac Dysfunction in Rats
title_fullStr Increased Dietary Leucine Reduces Doxorubicin-Associated Cardiac Dysfunction in Rats
title_full_unstemmed Increased Dietary Leucine Reduces Doxorubicin-Associated Cardiac Dysfunction in Rats
title_sort Increased Dietary Leucine Reduces Doxorubicin-Associated Cardiac Dysfunction in Rats
author Fidale, Thiago Montes
author_facet Fidale, Thiago Montes
Antunes, Hanna Karen Moreira [UNIFESP]
Santos, Luciano Alex dos
Souza, Fernanda Rodrigues de
Deconte, Simone Ramos
Moura, Francyelle Borges Rosa de
Mantovani, Matheus Matioli
Alves, Poliana Rodrigues
Roever, Leonardo
Resende, Elmiro Santos
author_role author
author2 Antunes, Hanna Karen Moreira [UNIFESP]
Santos, Luciano Alex dos
Souza, Fernanda Rodrigues de
Deconte, Simone Ramos
Moura, Francyelle Borges Rosa de
Mantovani, Matheus Matioli
Alves, Poliana Rodrigues
Roever, Leonardo
Resende, Elmiro Santos
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.institution.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Fidale, Thiago Montes
Antunes, Hanna Karen Moreira [UNIFESP]
Santos, Luciano Alex dos
Souza, Fernanda Rodrigues de
Deconte, Simone Ramos
Moura, Francyelle Borges Rosa de
Mantovani, Matheus Matioli
Alves, Poliana Rodrigues
Roever, Leonardo
Resende, Elmiro Santos
dc.subject.eng.fl_str_mv Doxorubicin
Cardiotoxicity
Leucine
BCAA
Heart failure
topic Doxorubicin
Cardiotoxicity
Leucine
BCAA
Heart failure
description Cardiotoxicity is one of the most significant adverse effects of the oncologic treatment with doxorubicin, which is responsible for a substantial morbid and mortality. The occurrence of heart failure with ventricular dysfunction may lead to severe cardiomyopathy and ultimately to death. Studies have focused on the effects of leucine supplementation as a strategy to minimize or revert the clinical condition of induced proteolysis by several clinical onsets. However, the impact of leucine supplementation in heart failure induced by doxorubicin is unknown. Therefore, the objective of this work is to evaluate the effects of leucine supplementation on the cardiotoxicity in the heart of rats treated with doxorubicin. Rats treated with a 7.5 mg/kg cumulative dose of doxorubicin for 14 days presented a dilatation of the left ventricle (LV), and a reduction of the ejection fraction (FE). The 5% supplementation of leucine in the rats' food prevented the malfunctioning of the LV when administered with doxorubicin. Some alterations in the extracellular matrix remodeling were confirmed by the increase of collagen fibers in the doxorubicin group, which did not increase when the treatment was associated with leucine supplementation. Leucine attenuates heart failure in this experimental model with doxorubicin. Such protection is followed by the maintenance of interstitial collagen fibers.
publishDate 2018
dc.date.issued.fl_str_mv 2018
dc.date.accessioned.fl_str_mv 2020-07-08T13:09:52Z
dc.date.available.fl_str_mv 2020-07-08T13:09:52Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv Frontiers In Physiology. Lausanne, v. 8, p. -, 2018.
dc.identifier.uri.fl_str_mv https://repositorio.unifesp.br/handle/11600/54261
https://dx.doi.org/10.3389/fphys.2017.01042
dc.identifier.issn.none.fl_str_mv 1664-042X
dc.identifier.file.none.fl_str_mv WOS000422692600001.pdf
dc.identifier.doi.none.fl_str_mv 10.3389/fphys.2017.01042
dc.identifier.wos.none.fl_str_mv WOS:000422692600001
identifier_str_mv Frontiers In Physiology. Lausanne, v. 8, p. -, 2018.
1664-042X
WOS000422692600001.pdf
10.3389/fphys.2017.01042
WOS:000422692600001
url https://repositorio.unifesp.br/handle/11600/54261
https://dx.doi.org/10.3389/fphys.2017.01042
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Frontiers In Physiology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv -
dc.coverage.none.fl_str_mv Lausanne
dc.publisher.none.fl_str_mv Frontiers Media Sa
publisher.none.fl_str_mv Frontiers Media Sa
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
bitstream.url.fl_str_mv ${dspace.ui.url}/bitstream/11600/54261/1/WOS000422692600001.pdf
${dspace.ui.url}/bitstream/11600/54261/5/WOS000422692600001.pdf.txt
${dspace.ui.url}/bitstream/11600/54261/7/WOS000422692600001.pdf.jpg
bitstream.checksum.fl_str_mv 849526b823b58bb0b9632c3eaca9dc5a
8244cb749f3c37506549e1ebddb287d0
e60fa0dfc9d4d79cc430a4676af17b05
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1802764273572642816